about
Molecular control of the cytosolic aconitase/IRP1 switch by extramitochondrial frataxinIn vivo maturation of human frataxinA pool of extramitochondrial frataxin that promotes cell survivalCaspase-dependent cleavage of c-Abl contributes to apoptosis.Src kinase phosphorylates Caspase-8 on Tyr380: a novel mechanism of apoptosis suppressionAnalysis of intracellular distribution and apoptosis involvement of the Ufd1l gene product by over-expression studies.Frataxin participates to the hypoxia-induced response in tumorsHighly specific ubiquitin-competing molecules effectively promote frataxin accumulation and partially rescue the aconitase defect in Friedreich ataxia cells.Interferon gamma upregulates frataxin and corrects the functional deficits in a Friedreich ataxia model.Autophagy induction extends lifespan and reduces lipid content in response to frataxin silencing in C. elegans.E3 Ligase RNF126 Directly Ubiquitinates Frataxin, Promoting Its Degradation: Identification of a Potential Therapeutic Target for Friedreich Ataxia.ATM kinase activity modulates Fas sensitivity through the regulation of FLIP in lymphoid cells.Acetylation suppresses the proapoptotic activity of GD3 ganglioside.A novel aminopeptidase associated with the 60 kDa chaperonin in the thermophilic archaeon Sulfolobus solfataricus.Cis-acting signals controlling translational initiation in the thermophilic archaeon Sulfolobus solfataricus.Reduced expression of frataxin extends the lifespan of Caenorhabditis elegans.Src inhibitors modulate frataxin protein levels.Fibroblast growth factor-2 transiently activates the p53 oncosuppressor protein in human primary vascular smooth muscle cells: implications for atherogenesis.Site-directed mutagenesis techniques in the study of Escherichia coli serine hydroxymethyltransferase.Preventing the ubiquitin–proteasome-dependent degradation of frataxin, the protein defective in Friedreich's ataxiaC. elegans as a model for Friedreich AtaxiaDrug repositioning screening identifies etravirine as a potential therapeutic for friedreich's ataxiaA caspaselike activity is triggered by LPS and is required for survival of human dendritic cellsSafety and efficacy of interferon γ in friedreich's ataxia
P50
Q24294287-2E4DAA37-8174-40E4-9997-C7261EFF22B7Q24304209-DB720F38-B31B-402F-ACC9-B5D4D8870F08Q24316486-43330949-A37D-4167-BFA8-DD9D04C9FEB2Q33186569-F54EB866-6C3A-41ED-B501-DF81CDDFB650Q33995107-4E8F0BF9-6D82-4532-A6AD-B9EE90DBDAC9Q34221235-3E46F8EF-BDC5-4D93-AB4B-7BC5B6F51B56Q35006031-8B56B8F0-0541-46E0-8905-5DA312B1512DQ35174542-C2B8FAE7-E3AA-44F0-9D2F-49499162C407Q36026884-1A064506-3ED7-44B2-B362-2FBCC4628330Q36609833-5392E1BC-141A-464C-AF15-821334450058Q37670668-3986E478-E948-4E4E-9F96-0B568AEEF517Q40068747-042C714F-A589-4EBD-948C-F12A7F4A3184Q40683016-1081CB0C-EA95-4FE8-BF12-975509F7E4C7Q43025663-1BBFCC2B-5E5A-41C5-A30D-4874870CC4F9Q43026995-CD6D065E-0C94-42D4-B61C-DBD02B6D383CQ47069249-2987C7D8-1FF6-4E38-AFC6-D480C541D96FQ53516540-B1FE20ED-61D6-45E0-A240-A8F80C44598DQ54443721-730404D4-5593-4411-A56B-AEA2E6B8421EQ54589007-E16A0092-D2D4-46A5-9204-B28FE8B0CA36Q63090656-C4E38092-7B31-47A5-8CC5-A99A9B106A1BQ63951771-609DA44A-956D-42F1-A4BE-16C105D098A3Q64216227-645BC0DC-CBB5-4476-A2F4-57BFA9D9C59AQ73581751-C77708E0-38CB-4414-9F2A-BE5AAD66C2A2Q92597194-A874979D-F523-4E93-8AE6-190BC8A13FEA
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Ivano Condò
@ast
Ivano Condò
@en
Ivano Condò
@es
Ivano Condò
@nl
Ivano Condò
@sl
type
label
Ivano Condò
@ast
Ivano Condò
@en
Ivano Condò
@es
Ivano Condò
@nl
Ivano Condò
@sl
prefLabel
Ivano Condò
@ast
Ivano Condò
@en
Ivano Condò
@es
Ivano Condò
@nl
Ivano Condò
@sl
P1053
B-4783-2010
P106
P1153
6603375964
P21
P31
P3829
P496
0000-0001-5421-4846